Skip to content
Cusatuzumab
Cusatuzumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target CD70 antigen.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470C92.0324
Myelodysplastic syndromesD009190D46122
NeoplasmsD009369C80212
Myelomonocytic leukemia chronicD015477C93.111
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCUSATUZUMAB
INNcusatuzumab
Description
Cusatuzumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target CD70 antigen.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297891
ChEBI ID
PubChem CID
DrugBank
UNII IDRR5U4UFJ8L (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CD70
CD70
Organism
Homo sapiens
Gene name
CD70
Gene synonyms
CD27L, CD27LG, TNFSF7
NCBI Gene ID
Protein name
CD70 antigen
Protein synonyms
CD27 ligand, CD27-L, CD70, Ki-24 antigen, surface antigen CD70, tumor necrosis factor ligand 8A, Tumor necrosis factor ligand superfamily member 7
Uniprot ID
Mouse ortholog
Cd70 (21948)
CD70 antigen (O55237)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 76 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details